BioNexus Gene Lab Corp. (BGLC) Total liabilities 2018–2025
BioNexus Gene Lab Corp. (BGLC) total liabilities at each fiscal year-end, per SEC filings.
$637,856FY2025 · since FY2018: $130,313 → $637,856
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $637,856 | -69.8% |
| FY2024 | $2.1M | +21.2% |
| FY2023 | $1.7M | -16.1% |
| FY2022 | $2.1M | -13.3% |
| FY2021 | $2.4M | -30.7% |
| FY2020 | $3.5M | +3071.7% |
| FY2019 | $108,872 | -16.5% |
| FY2018 | $130,313 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice